Verve Therapeutics Inc Sustainability Reports
Verve Therapeutics Inc. develops gene editing therapies for cardiovascular diseases as a publicly traded biotechnology company in the United States.
Sector: Health Care
Country: United States
Exchange: Nasdaq Stock Market
ISIN: US92539P1012
3 reports from 2021 to 2023
Company Profile
Verve Therapeutics Inc
Verve Therapeutics Inc. develops gene editing therapies for cardiovascular diseases as a publicly traded biotechnology company in the United States.
Reports